These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34284138)

  • 1. Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo.
    Kayiba NK; Yobi DM; Tchakounang VRK; Mvumbi DM; Kabututu PZ; Devleesschauwer B; Mukomena ES; DeMol P; Hayette MP; Mvumbi GL; Rosas-Aguirre A; Lusamba PD; Speybroeck N
    Infect Genet Evol; 2021 Oct; 94():105009. PubMed ID: 34284138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
    Ruh E; Bateko JP; Imir T; Taylan-Ozkan A
    Malar J; 2018 Jan; 17(1):17. PubMed ID: 29316929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
    Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
    Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of sulfadoxine-pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention.
    van Lenthe M; van der Meulen R; Lassovski M; Ouabo A; Bakula E; Badio C; Cibenda D; Okell L; Piriou E; Grignard L; Lanke K; Rao B; Bousema T; Roper C
    Malar J; 2019 Dec; 18(1):430. PubMed ID: 31852480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
    Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
    Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
    Tan KR; Katalenich BL; Mace KE; Nambozi M; Taylor SM; Meshnick SR; Wiegand RE; Chalwe V; Filler SJ; Kamuliwo M; Craig AS
    Malar J; 2014 Jun; 13():227. PubMed ID: 24909578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
    Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
    Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).
    Likwela JL; D'Alessandro U; Lokwa BL; Meuris S; Dramaix MW
    Trop Med Int Health; 2012 Mar; 17(3):322-9. PubMed ID: 22212628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
    Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
    Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
    Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
    PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
    Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
    Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation.
    Figueroa-Romero A; Bissombolo D; Meremikwu M; Ratsimbasoa A; Sacoor C; Arikpo I; Lemba E; Nhama A; Rakotosaona R; Llach M; Pons-Duran C; Sanz S; Ma L; Doderer-Lang C; Maly C; Roman E; Pagnoni F; Mayor A; Menard D; González R; Menéndez C
    Lancet Glob Health; 2023 Nov; 11(11):e1765-e1774. PubMed ID: 37858587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
    Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO
    PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
    Mama A; Ahiabor C; Tornyigah B; Frempong NA; Kusi KA; Adu B; Courtin D; Houzé S; Deloron P; Ofori MF; Anang AK; Ariey F; Ndam NT
    Malar J; 2022 Mar; 21(1):107. PubMed ID: 35346205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of dhfr/dhps multiple mutations and Plasmodium falciparum submicroscopic gametocyte carriage in Gabonese pregnant women following IPTp-SP implementation.
    Bouyou-Akotet MK; Tshibola ML; Mawili-Mboumba DP; Nzong J; Bahamontes-Rosa N; Tsoumbou-Bakana G; Kombila M
    Acta Parasitol; 2015 Jun; 60(2):218-25. PubMed ID: 26203988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
    Gikunju SW; Agola EL; Ondondo RO; Kinyua J; Kimani F; LaBeaud AD; Malhotra I; King C; Thiong'o K; Mutuku F
    Malar J; 2020 May; 19(1):190. PubMed ID: 32448228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
    J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.